查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861434

造影剂市场依造影类型、给药方式、应用、最终用户和分销管道划分－2025-2032年全球预测

Imaging Agents Market by Agent Type, Modality, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，造影剂市场规模将达到 159.9 亿美元，复合年增长率为 5.82%。

主要市场统计数据
基准年 2024 101.7亿美元
预计年份：2025年 107.6亿美元
预测年份：2032年 159.9亿美元
复合年增长率 (%) 5.82%

本文引言阐述了不断变化的临床需求、技术的融合以及法规环境的变迁如何重塑全球造影生态系统。

造影对比技术处于临床需求、技术进步和监管三者交汇的领域，使其成为整个诊断管道创新的焦点。患者群体老化以及更早期、更精准的疾病检测模式，正促使製药、诊断和医疗服务领域的相关人员重新评估其优先事项，以满足人们对安全性、特异性和工作流程效率日益增长的期望。分子影像技术的进步、超音波造影技术的改进以及人们对放射性药物日益增长的兴趣，共同拓展了诊断能力，同时也为生产、分销和报销带来了新的复杂性。

分析美国于2025年实施关税后，对营运、采购和商业性的累积影响以及供应链后果

2025年关税对造影剂供应链产生了多方面的影响，从组件采购到临床应用，各个环节都受到了波及。进口原料和成品关税的提高，使得依赖跨境供应链取得造影剂前驱物、放射性核种组件和专用包装材料的製造商的采购流程变得更加复杂。因此，各机构正在加快评估替代筹资策略，包括利用本地供应商、建立多源供应体係以及进行策略性储备，以降低供应中断的风险。

详细的細項分析说明了药物类型、成像方式、临床应用、最终用户和分销管道如何为每个相关人员创造不同的策略要务。

分析结果揭示了造影剂类型、影像方式、临床应用、最终用户和分销模式所带来的独特机会和挑战。依造影剂类型分析，钆基造影剂、碘基造影剂、微气泡造影剂和放射性药物各自呈现不同的发展趋势，其中放射性药物又可进一步细分为PET和SPECT通道，这两种通道需要专门的生产过程和监管。这种多样性要求针对每类造影剂独特的稳定性、操作特性和监管要求，制定量身订製的研发策略和生产投资方案。

透过对主要地区影像技术应用趋势的深入分析，提供区域性洞察：揭示不同的法规结构、临床重点和基础设施能力如何影响各主要地区（美洲、欧洲、中东和非洲以及亚太地区）的影像技术应用。

区域趋势正在显着影响美洲、欧洲、中东和非洲以及亚太地区的应用模式、监管方式和商业策略。在美洲，学术医疗中心和综合医疗系统的集中应用正在加速先进示踪剂和以金额为准的影像方法的普及，而供应链的韧性和报销谈判仍然是商业领域关注的核心问题。美洲的监管环境兼顾了严格的安全监测和针对特定适应症的加速临床应用管道，鼓励製造商使证据的产生与支付方的期望保持一致。

关键的竞争和策略性公司洞察，阐述了製造、伙伴关係、分销和数位化整合的能力将如何决定市场定位和差异化。

主要企业之间的竞争动态揭示了几个将塑造产业发展轨迹的策略重点。在放射化学、契约製造和监管事务方面拥有深厚实力的公司，预计将充分利用放射性药物的特殊需求；而专注于传统造影的公司则透过配方改进和加强上市后监测来解决安全性和耐受性问题。策略伙伴关係和联盟模式日益普遍，透过技术转移、联合临床开发和共同商业化安排，在扩大市场覆盖范围的同时，有效控制了资本密集度。

针对产业领导者的具体策略建议，重点在于加强供应链韧性、有针对性的研发、建立伙伴关係关係、协调医保报销以及收集证据，以推动永续成长。

产业领导者可以采取切实可行的策略行动，以应对不断变化的临床需求、复杂的监管环境和供应链压力。首先，投资于具有韧性的供应链结构，包括区域製造地和多元化的采购管道，可以降低受贸易政策波动和物流中断影响的风险。其次，研发工作应优先考虑提高安全性和临床差异化，这将有助于接受监管审查，并透过改善患者疗效和更清晰的价值提案来促进临床应用。

本研究采用的调查方法调查方法结合了多种一手和二手研究资讯来源、专家检验和三角测量技术，以得出可靠且可操作的市场洞察。

本分析的调查方法旨在结合定性和定量方法，以提供可靠且可操作的见解。主要研究包括对参与造影剂研发、生产和分销的临床负责人、监管专家、采购专家和商业高管进行结构化访谈，从而获得关于临床应用驱动因素、供应链挑战以及近期政策变化对商业影响的第一手资讯。

总之，我们综合分析了技术创新、安全优先事项和供应链调整如何塑造造影介质价值链中所有相关人员的策略要务。

总之，造影领域呈现出快速的技术进步、日益增长的安全期望以及受供应链和政策趋势驱动的商业性压力变化等特征。这些因素既给製造商、经销商、临床用户和支付方带来了挑战，也带来了机会。积极投资于更安全的化学配方、供应链韧性和整合诊断解决方案的机构，将更有能力满足临床医生的需求，并在竞争日益激烈的采购环境中脱颖而出。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 镓-68基PET示踪剂在神经内分泌肿瘤影像和治疗诊断学的应用日益广泛
  • 针对肿瘤学研究中分子生物标记的超高场磁振造影造影剂的进展
  • 用于术中癌症检测的多模态造影剂，结合了光学和核子医学标记，其发展迅速
  • 监理机关核准加速PSMA标靶放射性示踪剂在摄护腺癌诊断中的商业化进程
  • 开发基于奈米颗粒的造影剂，用于心血管成像中的靶向递送和降低毒性
  • 加大对氟-18标记示踪剂的投资，用于神经病学和心臟病学领域的常规临床PET应用
  • 用于即时监测发炎疾病进展的生物工程酶活化成像探针
  • 透过製药公司与学术机构之间的合作，提高放射化学供应链的效率

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章造影剂市场（依造影剂类型划分）

  • 钆基造影剂
  • 碘造影剂
  • 微气泡造影剂
  • 放射性药物
    • PET造影剂
    • SPECT造影剂

第九章 以模态分類的造影剂市场

  • 电脑断层扫描（CT）
  • 磁振造影
  • 核子医学影像
    • PET造影剂
    • 频谱成像剂
  • 超音波成像
    • 3D造影剂
    • 二维造影剂

第十章 按应用分類的显影剂市场

  • 心臟病学
  • 胃肠病学
  • 肌肉骨骼系统
  • 神经病学
  • 肿瘤学

第十一章 以最终用户造影的造影剂市场

  • 学术研究机构
  • 门诊手术中心
  • 诊断实验室
  • 医院及影像中心

第十二章 按通路造影的造影剂市场

  • 直销
  • 经销商
    • 国际经销商
    • 区域经销商
  • 线上零售

第十三章 各地区的造影市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章造影剂市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国媒体市场造影

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE Healthcare
    • Bayer AG
    • Bracco Imaging SpA
    • Guerbet SA
    • Lantheus Holdings, Inc.
    • Siemens Healthineers AG
    • Mallinckrodt plc
    • Fujifilm Holdings Corporation
    • Sagent Pharmaceuticals, Inc.
    • Cardinal Health, Inc.
Product Code: MRR-69324464D0E7

The Imaging Agents Market is projected to grow by USD 15.99 billion at a CAGR of 5.82% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 10.17 billion
Estimated Year [2025] USD 10.76 billion
Forecast Year [2032] USD 15.99 billion
CAGR (%) 5.82%

Introduction describing how evolving clinical demands, technological convergence, and regulatory dynamics are reshaping the global imaging agents ecosystem

The landscape of imaging agents sits at the intersection of clinical need, technological progress, and regulatory scrutiny, making it a focal point for innovation across diagnostic pathways. As patient populations age and disease detection paradigms shift toward earlier and more precise modalities, stakeholders across pharma, diagnostics, and healthcare delivery are recalibrating priorities to align with heightened expectations for safety, specificity, and workflow efficiency. Advancements in molecular imaging, improvements in ultrasound contrast technologies, and renewed interest in radiopharmaceuticals are converging to broaden diagnostic capabilities while also introducing new complexities in manufacturing, distribution, and reimbursement.

Across clinical specialties, imaging agents now play a central role not only in diagnosis but also in treatment planning and therapy monitoring. This expanded utility elevates demands on clinical validation, post-market surveillance, and interoperability with imaging platforms. In response, manufacturers and clinical partners are investing in evidence generation, standardized protocols, and digital tools that enhance image quantitation and reporting. Consequently, the ecosystem is evolving from a product-centric model toward integrated diagnostic solutions that combine agents, instrumentation, and analytics to deliver higher-value clinical outcomes.

The imaging agents sector is undergoing transformative shifts driven by technological innovation, heightened safety expectations, and a rapidly evolving regulatory environment. Molecular imaging advances are enabling greater target specificity, which in turn supports precision medicine approaches and more nuanced patient stratification. Concurrently, concerns about contrast safety-particularly around long-term retention and nephrotoxicity-have elevated the importance of agent chemistries and post-market data, prompting manufacturers to prioritize safer formulations and to invest in comparative clinical studies.

Technological convergence is another defining trend: hybrid imaging systems and enhanced image processing algorithms are increasing the diagnostic yield of established agents while stimulating demand for new tracers and contrast media optimized for quantitative imaging. In parallel, digital health tools, including AI-driven image analysis and cloud-based workflows, are changing how imaging agents are used in care pathways and research. These shifts are forcing traditional players to adopt cross-disciplinary strategies, forging partnerships with device manufacturers, software innovators, and clinical research organizations to maintain competitiveness and to deliver integrated solutions across clinical settings.

Analysis of the cumulative operational, procurement, and commercial effects stemming from the United States tariff measures enacted in 2025 and their supply chain consequences

The imposition of tariff measures in 2025 has produced a multifaceted impact on the imaging agents supply chain, creating ripple effects that extend from component sourcing to clinical deployment. Increased duties on imported raw materials and finished agents have elevated procurement complexity for manufacturers that rely on cross-border supply chains for contrast media precursors, radionuclide components, and specialized packaging materials. As a result, organizations have accelerated evaluations of alternative sourcing strategies, including local suppliers, multi-sourcing frameworks, and strategic stockpiling to mitigate disruption risks.

These trade policy changes have also influenced commercial dynamics. Healthcare providers and distributors are reassessing contract terms and pricing structures to manage margin pressures while maintaining service levels. Payers and hospital procurement teams are emphasizing cost-effectiveness and supply resiliency when selecting agents and vendors, prompting suppliers to demonstrate operational flexibility and value beyond unit pricing. In addition, regulatory and customs processes have required closer coordination, with firms enhancing compliance capabilities and logistics planning to reduce lead times and preserve continuity of care. Collectively, these adaptations underscore an industry-wide emphasis on supply chain robustness, collaborative contracting, and strategic operational agility.

In-depth segmentation insights explaining how agent types, imaging modalities, clinical applications, end users, and distribution channels create distinct strategic imperatives for stakeholders

Segmentation-based insights reveal differentiated opportunities and challenges across agent types, imaging modalities, clinical applications, end users, and distribution models. When analyzed by agent type, trends show distinct trajectories for gadolinium-based agents, iodinated contrast agents, microbubble agents, and radiopharmaceuticals, with radiopharmaceuticals further delineated into PET and SPECT pathways that demand specialized manufacturing and regulatory oversight. This diversity necessitates tailored R&D strategies and manufacturing investments to address the unique stability, handling, and regulatory profiles of each category.

From a modality perspective, computed tomography, magnetic resonance imaging, nuclear imaging, and ultrasound imaging each present different clinical and operational imperatives. Nuclear imaging requires close integration with PET and SPECT infrastructures and radiopharmacy networks, while ultrasound innovations encompass both two-dimensional and three-dimensional contrast agent applications that are more accessible in point-of-care environments. Clinical application segmentation highlights the varying agent requirements across cardiology, gastroenterology, musculoskeletal, neurology, and oncology, with oncology and neurology generally driving demand for higher specificity agents and more rigorous validation.

End-user segmentation illustrates how academic research institutes, ambulatory surgical centers, diagnostic laboratories, and hospitals and imaging centers adopt and deploy agents differently, with research institutions often prioritizing novel tracers and hospitals focusing on operational reliability and throughput. Distribution channel segmentation, spanning direct sales, distributors, and online retail, underscores the strategic importance of distribution partners; distributors themselves are differentiated into international and local distributors, each offering distinct reach, regulatory familiarity, and logistical capabilities that must be matched to product profiles and customer needs.

Key regional insights detailing how distinct regulatory frameworks, clinical priorities, and infrastructure capacities are influencing imaging agent adoption across major global regions

Regional dynamics shape adoption patterns, regulatory approaches, and commercial strategies in meaningful ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of academic medical centers and integrated healthcare systems accelerates adoption of advanced tracers and value-based imaging approaches, while supply chain resilience and reimbursement negotiations remain central commercial concerns. The regulatory landscape in the Americas combines rigorous safety oversight with pathways for accelerated clinical adoption in select indications, prompting manufacturers to align evidence generation with payer expectations.

Europe, Middle East & Africa presents a heterogeneous set of regulatory regimes and healthcare delivery models, where centralized regulatory frameworks coexist with country-specific reimbursement and procurement mechanisms. This complexity rewards companies that invest in localized regulatory strategy and regionally tailored clinical programs. In the Asia-Pacific region, market dynamics are characterized by rapid infrastructure expansion, growing clinical research capacity, and an increasing emphasis on point-of-care imaging solutions. Local manufacturing capabilities and regional distribution partnerships are pivotal for scaling adoption, especially as clinical demand diversifies across oncology, cardiology, and neurology applications. Collectively, regional insights point to the importance of adaptive regulatory strategies, localized partnerships, and differentiated commercial approaches.

Key competitive and strategic company insights outlining how capabilities in manufacturing, partnerships, distribution, and digital integration are determining market positioning and differentiation

Competitive dynamics among leading organizations reveal several strategic priorities that are shaping the sector's trajectory. Companies with deep capabilities in radiochemistry, contract manufacturing, and regulatory affairs are positioned to capitalize on the specialized demands of radiopharmaceuticals, whereas firms focused on conventional contrast media are responding to safety and tolerability concerns through reformulation and enhanced post-market surveillance. Strategic partnerships and alliance models are increasingly common, enabling technology transfer, shared clinical development, and co-commercialization arrangements that extend market reach while managing capital intensity.

Manufacturers are also diversifying distribution strategies, balancing direct sales with distributor partnerships to optimize access across hospitals, diagnostic centers, and ambulatory settings. Concurrently, investment in quality systems, cold-chain logistics for temperature-sensitive agents, and compliance capabilities has become a competitive differentiator. In addition, a subset of actors is prioritizing the integration of digital tools and analytics to add demonstrable clinical value, improve imaging workflow efficiency, and support outcomes-based contracting discussions with payers. These trends indicate that success will favor organizations that combine technical excellence with operational flexibility and evidence-driven commercialization models.

Actionable strategic recommendations for industry leaders focused on supply chain resilience, targeted R&D, partnerships, reimbursement alignment, and evidence generation to drive sustainable growth

Industry leaders can pursue a practical set of strategic actions to navigate evolving clinical needs, regulatory complexity, and supply chain pressures. First, investing in resilient supply chain architectures, including regional manufacturing hubs and multi-sourced procurement, reduces vulnerability to trade policy shocks and logistical disruption. Second, aligning R&D priorities with safety enhancements and clinical differentiation helps address regulatory scrutiny and strengthens clinical adoption by delivering better patient outcomes and clearer value propositions.

Third, forming targeted alliances with device manufacturers, clinical research organizations, and digital health vendors accelerates the development of integrated diagnostic solutions that combine agents with imaging platforms and analytics. Fourth, cultivating payer engagement and designing evidence packages that demonstrate clinical utility and cost-effectiveness facilitate smoother reimbursement pathways. Fifth, optimizing distribution strategies by combining direct engagement in major accounts with partnerships for regional reach ensures operational efficiency and market coverage. Finally, enhancing post-market surveillance, real-world evidence generation, and clinician education programs builds trust with end users and supports long-term adoption across diverse clinical settings.

Research methodology describing the multi-source primary and secondary approaches, expert validation, and triangulation techniques used to derive robust, actionable market insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to deliver robust, actionable insights. Primary research included structured interviews with clinical leaders, regulatory experts, procurement specialists, and commercial executives involved in imaging agent development, manufacturing, and distribution. These interviews provided first-hand perspectives on clinical adoption drivers, supply chain challenges, and the commercial implications of recent policy changes.

Secondary research encompassed systematic review of regulatory filings, clinical trial registries, patent literature, and peer-reviewed publications to contextualize technological trends and safety considerations. In addition, supply chain mapping and logistics data were analyzed to understand the operational implications of tariff changes and to identify critical nodes of vulnerability. Findings were triangulated across data sources and validated through expert workshops, ensuring consistency and relevancy. Finally, methodological limitations and areas of uncertainty were documented, with transparency around data sources and assumptions to support informed decision-making by stakeholders.

Conclusion synthesizing how technological innovation, safety priorities, and supply chain adaptations will shape strategic imperatives for all stakeholders across the imaging agents value chain

In conclusion, the imaging agents landscape is characterized by rapid technological progress, intensifying safety expectations, and evolving commercial pressures driven by supply chain and policy dynamics. These forces are creating both challenges and opportunities for manufacturers, distributors, clinical users, and payers. Organizations that proactively invest in safer chemistries, supply chain resilience, and integrated diagnostic solutions are better positioned to meet clinician needs and to differentiate in increasingly competitive procurement environments.

Moving forward, success will hinge on cross-functional collaboration that links scientific innovation with pragmatic operational and commercial strategies. By prioritizing evidence generation, regulatory engagement, and strategic partnerships, stakeholders can accelerate clinical adoption while managing the operational complexities introduced by trade policy shifts and regional regulatory variance. Ultimately, a balanced focus on clinical value, operational robustness, and commercial adaptability will define which actors lead the next phase of evolution in imaging agents.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of gallium-68 based PET tracers for neuroendocrine tumor imaging and theranostics
  • 5.2. Advancements in ultra-high field MRI contrast agents targeting molecular biomarkers in oncology research
  • 5.3. Growth of multimodal imaging agents combining optical and nuclear labels for intraoperative cancer detection
  • 5.4. Regulatory approvals accelerating commercialization of PSMA-targeted radiotracers in prostate cancer diagnostics
  • 5.5. Development of nanoparticle-based contrast agents enabling targeted delivery and reduced toxicity in cardiovascular imaging
  • 5.6. Increasing investment in fluorine-18 labeled tracers for routine clinical PET applications in neurology and cardiology
  • 5.7. Emergence of bioengineered enzyme-activated imaging probes for real-time monitoring of inflammatory disease progression
  • 5.8. Collaborations between pharmaceutical companies and academic institutions to streamline radiochemistry supply chains

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Imaging Agents Market, by Agent Type

  • 8.1. Gadolinium Based Agents
  • 8.2. Iodinated Contrast Agents
  • 8.3. Microbubble Agents
  • 8.4. Radiopharmaceuticals
    • 8.4.1. Pet Imaging Agents
    • 8.4.2. Spect Imaging Agents

9. Imaging Agents Market, by Modality

  • 9.1. Computed Tomography
  • 9.2. Magnetic Resonance Imaging
  • 9.3. Nuclear Imaging
    • 9.3.1. Pet Imaging Agents
    • 9.3.2. Spect Imaging Agents
  • 9.4. Ultrasound Imaging
    • 9.4.1. Three D Imaging Agents
    • 9.4.2. Two D Imaging Agents

10. Imaging Agents Market, by Application

  • 10.1. Cardiology
  • 10.2. Gastroenterology
  • 10.3. Musculoskeletal
  • 10.4. Neurology
  • 10.5. Oncology

11. Imaging Agents Market, by End User

  • 11.1. Academic Research Institutes
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals And Imaging Centers

12. Imaging Agents Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. International Distributors
    • 12.2.2. Local Distributors
  • 12.3. Online Retail

13. Imaging Agents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Imaging Agents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Imaging Agents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. GE Healthcare
    • 16.3.2. Bayer AG
    • 16.3.3. Bracco Imaging S.p.A.
    • 16.3.4. Guerbet S.A.
    • 16.3.5. Lantheus Holdings, Inc.
    • 16.3.6. Siemens Healthineers AG
    • 16.3.7. Mallinckrodt plc
    • 16.3.8. Fujifilm Holdings Corporation
    • 16.3.9. Sagent Pharmaceuticals, Inc.
    • 16.3.10. Cardinal Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMAGING AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IMAGING AGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS IMAGING AGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL IMAGING AGENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. IMAGING AGENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. IMAGING AGENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMAGING AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMAGING AGENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMAGING AGENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL IMAGING AGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL IMAGING AGENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS IMAGING AGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS IMAGING AGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA IMAGING AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2024